Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
- Inge Van Der Werf
- , Anna Wojtuszkiewicz
- , Manja Meggendorfer
- , Stephan Hutter
- , Constance Baer
- , Martijn Heymans
- , Peter J.M. Valk
- , Wolfgang Kern
- , Claudia Haferlach
- , Jeroen J.W.M. Janssen
- , Gert J. Ossenkoppele
- , Jacqueline Cloos
- , Torsten Haferlach
Research output: Contribution to journal › Article › peer-review
42
Citations
(Scopus)